Literature DB >> 15389988

Botulinum toxin type A therapy during pregnancy.

William J Newman1, Thomas L Davis, Bimal B Padaliya, Bismal B Padaliya, Cassondra D Covington, Chandler E Gill, Anna I Abramovitch, P David Charles.   

Abstract

Injection with botulinum toxin type A (Botox) is a safe and efficacious treatment for idiopathic cervical dystonia. We present the first case report of clinical Botox treatment during pregnancy. This patient underwent four apparently uncomplicated full-term pregnancies while receiving regular Botox treatments.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15389988     DOI： 10.1002/mds.20205

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  12 in total

1.  Botulinum toxin A during pregnancy: a survey of treating physicians.

Authors:  J C Morgan; S S Iyer; E T Moser; C Singer; K D Sethi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 2.  Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.

Authors:  Geoffrey Sheean
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Management of DYT1 dystonia throughout pregnancy.

Authors:  Sathiji Nageshwaran; Saiji Nageshwaran; Mark J Edwards; Michael Morcos
Journal:  BMJ Case Rep       Date:  2011-09-04

4.  Controversy: botulinum toxin in pregnancy.

Authors:  Munish Paul
Journal:  J Cutan Aesthet Surg       Date:  2009-01

5.  [Botulinum toxin in dermatology].

Authors:  W G Philipp-Dormston
Journal:  Hautarzt       Date:  2014-02       Impact factor: 0.751

6.  Botulinum toxin type A in pregnancy.

Authors:  Michael Tan; Eunji Kim; Gideon Koren; Pina Bozzo
Journal:  Can Fam Physician       Date:  2013-11       Impact factor: 3.275

7.  Safe Administration of Botulinum Toxin Type A Injections During Pregnancy: A Report of Two Cases.

Authors:  Henriette Krug; Patricia Krause; Andreas Kupsch; Andrea A Kühn
Journal:  Mov Disord Clin Pract       Date:  2015-05-06

Review 8.  Safety and Patient Satisfaction of AbobotulinumtoxinA for Aesthetic Use: A Systematic Review.

Authors:  Joel L Cohen; Nicolo Scuderi
Journal:  Aesthet Surg J       Date:  2017-05-01       Impact factor: 4.283

Review 9.  A review of the safety of cosmetic procedures during pregnancy and lactation.

Authors:  M K Trivedi; G Kroumpouzos; J E Murase
Journal:  Int J Womens Dermatol       Date:  2017-02-27

10.  Pregnancy outcomes following exposure to onabotulinumtoxinA.

Authors:  Mitchell F Brin; Russell S Kirby; Anne Slavotinek; Mary Ann Miller-Messana; Lori Parker; Irina Yushmanova; Huiying Yang
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-12-04       Impact factor: 2.890
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.